The effect of vancomycin on the corneal endothelium

T D Lindquist1, L D Robinson

  • 1Department of Ophthalmology, University of Washington, Seattle, USA.

Cornea
|January 1, 1996
PubMed

Insights

Vancomycin, an antibiotic, does not harm corneal endothelial cells in rabbits or human corneal transplant recipients. This study confirms vancomycin

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Cell Biology

Background:

  • Vancomycin is a critical antibiotic for treating serious bacterial infections.
  • Potential toxicity of vancomycin to the corneal endothelium requires investigation, especially for ophthalmic applications.

Purpose of the Study:

  • To evaluate the toxic effects of vancomycin on corneal endothelial cells in vivo using a rabbit model.
  • To assess the safety of vancomycin in corneal transplant recipients undergoing penetrating keratoplasty.

Main Methods:

  • Rabbit eyes received intracameral injections of balanced salt solution or varying concentrations of vancomycin; endothelial cell density and morphology were analyzed via specular microscopy and transmission electron microscopy.
  • Human corneal transplant recipients received donor corneas preserved in solutions with or without vancomycin; endothelial cell changes were monitored postoperatively using specular microscopy.

Main Results:

  • No statistically significant differences in corneal endothelial cell density or morphology were observed in rabbit eyes treated with vancomycin compared to controls.
  • Human corneal transplant recipients showed no significant adverse effects on endothelial cell counts or morphology at 3, 6, and 12 months postoperatively when corneas were preserved with vancomycin.

Conclusions:

  • Vancomycin, at therapeutic concentrations, does not exhibit toxic effects on the corneal endothelium in rabbits.
  • The use of vancomycin in corneal preservation solutions for penetrating keratoplasty appears safe and does not adversely impact endothelial cell function or survival.